Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoko Hosono

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 5, 2022
[Hematopoietic cell transplantation for FLT3-mutated acute myeloid leukemia]Naoko Hosono
International Journal of Clinical Oncology|April 17, 2026
The new era of AML therapy: current standards and emerging targetsNaoko Hosono
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 11, 2019
[New therapeutic agents for acute myeloid leukemia]Naoko Hosono
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 9, 2019
[Genetic defects of chromosome 5q and 7q in myeloid neoplasms]Naoko Hosono
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 2, 2024
[Future prospects for the development of novel agents for acute myeloid leukemia]Naoko Hosono
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 5, 2025
[Acute myeloid leukemia therapy in the era of comprehensive genomic profiling]Naoko Hosono
International Journal of Clinical Oncology|May 17, 2019
Genetic abnormalities and pathophysiology of MDSNaoko Hosono
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 17, 2022
[Ⅲ. Bcl-2 Inhibitor in AML Therapy]Naoko Hosono, Takahiro Yamauchi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 21, 2018
[I. Recent Progress in Therapies for Acute Myeloid Leukemia]Takahiro Yamauchi, Naoko Hosono
Experimental Hematology|October 3, 2024
Cellular uptake of CPX-351 by scavenger receptor class B type 1-mediated nonendocytic pathwayHiroaki Araie, Naoko Hosono, Takahiro Yamauchi
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 5, 2022
[Hematopoietic cell transplantation for FLT3-mutated acute myeloid leukemia]Naoko Hosono
International Journal of Clinical Oncology|April 17, 2026
The new era of AML therapy: current standards and emerging targetsNaoko Hosono
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 11, 2019
[New therapeutic agents for acute myeloid leukemia]Naoko Hosono
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 9, 2019
[Genetic defects of chromosome 5q and 7q in myeloid neoplasms]Naoko Hosono
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 2, 2024
[Future prospects for the development of novel agents for acute myeloid leukemia]Naoko Hosono
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 5, 2025
[Acute myeloid leukemia therapy in the era of comprehensive genomic profiling]Naoko Hosono
International Journal of Clinical Oncology|May 17, 2019
Genetic abnormalities and pathophysiology of MDSNaoko Hosono
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 17, 2022
[Ⅲ. Bcl-2 Inhibitor in AML Therapy]Naoko Hosono, Takahiro Yamauchi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 21, 2018
[I. Recent Progress in Therapies for Acute Myeloid Leukemia]Takahiro Yamauchi, Naoko Hosono
Experimental Hematology|October 3, 2024
Cellular uptake of CPX-351 by scavenger receptor class B type 1-mediated nonendocytic pathwayHiroaki Araie, Naoko Hosono, Takahiro Yamauchi
Pageof 7